Whole exome sequencing facilitates early neurodevelopmental diagnosis in an outpatient clinic
The American College of Medical Genetics and Genomics (ACMG) and other professional organisations recommend whole exome sequencing (WES) as a first-tier genetic test for paediatric patients with congenital anomalies, developmental delay and/or intellectual disability, which has contributed to rapidly increasing rates of genetic testing and diagnosis in this population. We present a case of Rett syndrome diagnosed in early childhood following an atypical presentation of the condition with no regression using WES. This diagnosis was facilitated by a multidisciplinary outpatient neurodevelopmental genetics programme. Non-genetics providers trained in consent for genetic testing allowed for ample access to a comprehensive genetics work-up. The subsequent diagnosis of Rett syndrome qualified this patient for additional resources, novel interventions and family support.
Authors
- Molly Lombard (ORCID: https://orcid.org/0009-0007-0114-8719)
- Celanie Christensen
- Evangeline Kurtz-Nelson
- Casaundra Gutowski
Institutions
- Indiana University Health (US)
- Riley Hospital for Children (US)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- BMJ Case Reports
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1136/bcr-2025-269337
- Primary Topic
- Genetics and Neurodevelopmental Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00